| Literature DB >> 19890966 |
Francesca Favini1, Antonio Giordano Resti, Paola Collini, Michela Casanova, Cristina Meazza, Giovanna Trecate, Andrea Ferrari.
Abstract
Inflammatory myofibroblastic tumor (IMT) is an unusual entity that mainly affects children and young adults, and for which standardized therapies for inoperable cases are still lacking. We report on a 12-year-old patient with an extremely rare and inoperable conjunctival location that was treated with chemotherapy using low-dose methotrexate plus vinorelbine, achieving complete tumor remission. This regimen is usually well tolerated and may be considered as the treatment of choice for cases of unresectable advanced IMT. Copyright 2009 Wiley-Liss, Inc.Entities:
Mesh:
Substances:
Year: 2010 PMID: 19890966 DOI: 10.1002/pbc.22342
Source DB: PubMed Journal: Pediatr Blood Cancer ISSN: 1545-5009 Impact factor: 3.167